Clinical Trial Update: Evaluation of Patients With Bulky GIST Using Sunitinib [NA]

View source ↗

Summary

Clinical trial evaluating sunitinib in patients with bulky gastrointestinal stromal tumors has been terminated; results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Tumor | NA | Status: TERMINATED | Results posted: 2016-06-03